| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | G protein-coupled serotonin receptor activity | 1.37e-04 | 22 | 92 | 3 | GO:0004993 | |
| GeneOntologyMolecularFunction | G protein-coupled acetylcholine receptor activity | 4.34e-04 | 7 | 92 | 2 | GO:0016907 | |
| GeneOntologyMolecularFunction | nucleoside-triphosphatase regulator activity | 5.49e-04 | 507 | 92 | 9 | GO:0060589 | |
| GeneOntologyMolecularFunction | GTPase regulator activity | 5.49e-04 | 507 | 92 | 9 | GO:0030695 | |
| GeneOntologyMolecularFunction | guanyl-nucleotide exchange factor activity | 6.99e-04 | 231 | 92 | 6 | GO:0005085 | |
| GeneOntologyMolecularFunction | G protein-coupled amine receptor activity | 8.89e-04 | 41 | 92 | 3 | GO:0008227 | |
| GeneOntologyCellularComponent | PcG protein complex | 7.75e-05 | 52 | 91 | 4 | GO:0031519 | |
| HumanPheno | Aggressive behavior | CUL4B JARID2 ATRX TRIO KMT5B UBAP2L IQSEC1 DEPDC5 CHD2 CNKSR2 POGZ KMT2E UNC80 MADD | 2.06e-06 | 516 | 34 | 14 | HP:0000718 |
| HumanPheno | Abnormal aggressive, impulsive or violent behavior | CUL4B JARID2 ATRX TRIO KMT5B UBAP2L IQSEC1 DEPDC5 CHD2 CNKSR2 POGZ KMT2E UNC80 MADD | 2.06e-06 | 516 | 34 | 14 | HP:0006919 |
| HumanPheno | Abnormality of the forehead | CUL4B JARID2 SPRED2 ATRX TRIO KMT5B UBAP2L GATA4 DEPDC5 CHD2 CNKSR2 ASXL2 POGZ HERC1 KMT2E CPLANE1 TRIM37 UNC80 IL6ST MADD | 1.16e-05 | 1208 | 34 | 20 | HP:0000290 |
| HumanPheno | Abnormality of calvarial morphology | CUL4B JARID2 SPRED2 ATRX TRIO KMT5B UBAP2L GATA4 DEPDC5 CNKSR2 POGZ HERC1 KMT2E CPLANE1 AHDC1 TRIM37 UNC80 IL6ST MADD | 2.01e-05 | 1134 | 34 | 19 | HP:0002648 |
| HumanPheno | Abnormal nasal tip morphology | CUL4B JARID2 ATRX TRIO UBAP2L AFF3 ASXL2 POGZ CPLANE1 UNC80 MADD | 2.38e-05 | 386 | 34 | 11 | HP:0000436 |
| HumanPheno | Frontal bossing | CUL4B JARID2 SPRED2 TRIO KMT5B UBAP2L GATA4 DEPDC5 CNKSR2 POGZ HERC1 CPLANE1 TRIM37 UNC80 MADD | 2.84e-05 | 738 | 34 | 15 | HP:0002007 |
| HumanPheno | Hyperactivity | CUL4B JARID2 ATRX TRIO KMT5B UBAP2L GATA4 IQSEC1 DEPDC5 CHD2 CNKSR2 POGZ MADD | 2.99e-05 | 558 | 34 | 13 | HP:0000752 |
| HumanPheno | Abnormal shape of the frontal region | CUL4B JARID2 SPRED2 TRIO KMT5B UBAP2L GATA4 DEPDC5 CNKSR2 POGZ HERC1 CPLANE1 TRIM37 UNC80 MADD | 2.99e-05 | 741 | 34 | 15 | HP:0011218 |
| HumanPheno | Abnormal frontal bone morphology | CUL4B JARID2 SPRED2 TRIO KMT5B UBAP2L GATA4 DEPDC5 CNKSR2 POGZ HERC1 CPLANE1 TRIM37 UNC80 MADD | 3.04e-05 | 742 | 34 | 15 | HP:0430000 |
| HumanPheno | Abnormality of the chin | CUL4B JARID2 SPRED2 ATRX TRIO UBAP2L AFF3 POGZ HERC1 IL6ST MADD | 4.10e-05 | 409 | 34 | 11 | HP:0000306 |
| HumanPheno | Downslanted palpebral fissures | CUL4B JARID2 SPRED2 TRIO GATA4 CNKSR2 POGZ HERC1 KMT2E AHDC1 UNC80 IL6ST | 4.80e-05 | 497 | 34 | 12 | HP:0000494 |
| HumanPheno | Abnormality of the palpebral fissures | CUL4B JARID2 SPRED2 ATRX TRIO UBAP2L AFF3 GATA4 CNKSR2 POGZ HERC1 KMT2E AHDC1 UNC80 IL6ST MADD | 5.44e-05 | 880 | 34 | 16 | HP:0008050 |
| HumanPheno | Abnormal social development | CUL4B JARID2 ATRX TRIO KMT5B UBAP2L GATA4 IQSEC1 DEPDC5 CHD2 CNKSR2 POGZ HERC1 KMT2E UNC80 MADD | 8.08e-05 | 908 | 34 | 16 | HP:0025732 |
| HumanPheno | Disinhibition | CUL4B JARID2 ATRX TRIO KMT5B UBAP2L GATA4 IQSEC1 DEPDC5 CHD2 CNKSR2 POGZ KMT2E UNC80 MADD | 8.34e-05 | 807 | 34 | 15 | HP:0000734 |
| HumanPheno | Inappropriate behavior | CUL4B JARID2 ATRX TRIO KMT5B UBAP2L GATA4 IQSEC1 DEPDC5 CHD2 CNKSR2 POGZ KMT2E UNC80 MADD | 8.34e-05 | 807 | 34 | 15 | HP:0000719 |
| HumanPheno | Abnormal response to social norms | CUL4B JARID2 ATRX TRIO KMT5B UBAP2L GATA4 IQSEC1 DEPDC5 CHD2 CNKSR2 POGZ KMT2E UNC80 MADD | 8.34e-05 | 807 | 34 | 15 | HP:5200123 |
| HumanPheno | Social disinhibition | CUL4B JARID2 ATRX TRIO KMT5B UBAP2L GATA4 IQSEC1 DEPDC5 CHD2 CNKSR2 POGZ KMT2E UNC80 MADD | 8.34e-05 | 807 | 34 | 15 | HP:5200029 |
| HumanPheno | Abnormal calvaria morphology | CUL4B JARID2 SPRED2 ATRX TRIO KMT5B UBAP2L GATA4 DEPDC5 CNKSR2 POGZ HERC1 KMT2E CPLANE1 AHDC1 TRIM37 UNC80 IL6ST MADD | 8.99e-05 | 1254 | 34 | 19 | HP:0002683 |
| HumanPheno | Abnormal nasal bridge morphology | CUL4B JARID2 SPRED2 ATRX TRIO KMT5B UBAP2L GATA4 CHD2 POGZ HERC1 CPLANE1 AHDC1 TRIM37 UNC80 IL6ST MADD | 9.59e-05 | 1029 | 34 | 17 | HP:0000422 |
| HumanPheno | Abnormal eyelid morphology | CUL4B JARID2 SPRED2 ATRX TRIO KMT5B UBAP2L AFF3 GATA4 DEPDC5 CNKSR2 ASXL2 POGZ HERC1 KMT2E CPLANE1 AHDC1 UNC80 IL6ST MADD | 1.28e-04 | 1408 | 34 | 20 | HP:0000492 |
| HumanPheno | Slanting of the palpebral fissure | CUL4B JARID2 SPRED2 ATRX TRIO UBAP2L GATA4 CNKSR2 POGZ HERC1 KMT2E AHDC1 UNC80 IL6ST | 1.34e-04 | 739 | 34 | 14 | HP:0200006 |
| HumanPheno | Low-set ears | JARID2 SPRED2 ATRX AFF3 GATA4 DEPDC5 ASXL2 POGZ HERC1 CPLANE1 AHDC1 UNC80 IL6ST MADD | 1.84e-04 | 761 | 34 | 14 | HP:0000369 |
| HumanPheno | Abnormally increased volition | CUL4B JARID2 ATRX TRIO KMT5B UBAP2L GATA4 IQSEC1 DEPDC5 CHD2 CNKSR2 POGZ KMT2E UNC80 MADD | 1.98e-04 | 869 | 34 | 15 | HP:5200263 |
| HumanPheno | Attention deficit hyperactivity disorder | JARID2 TRIO KMT5B UBAP2L GATA4 IQSEC1 DEPDC5 CHD2 CNKSR2 MADD | 2.44e-04 | 413 | 34 | 10 | HP:0007018 |
| HumanPheno | Infection-related seizure | 3.34e-04 | 145 | 34 | 6 | HP:0032892 | |
| HumanPheno | Seizure precipitated by febrile infection | 3.34e-04 | 145 | 34 | 6 | HP:0032894 | |
| HumanPheno | Febrile seizure (within the age range of 3 months to 6 years) | 3.34e-04 | 145 | 34 | 6 | HP:0002373 | |
| HumanPheno | Epicanthus | CUL4B JARID2 SPRED2 ATRX TRIO KMT5B UBAP2L GATA4 ASXL2 CPLANE1 UNC80 MADD | 3.74e-04 | 614 | 34 | 12 | HP:0000286 |
| HumanPheno | Self-injurious behavior | 3.81e-04 | 210 | 34 | 7 | HP:0100716 | |
| HumanPheno | Thick vermilion border | 3.81e-04 | 279 | 34 | 8 | HP:0012471 | |
| HumanPheno | Motor stereotypy | 3.91e-04 | 280 | 34 | 8 | HP:0000733 | |
| HumanPheno | Increased femoral anteversion | 4.27e-04 | 5 | 34 | 2 | HP:0012427 | |
| HumanPheno | Hypertelorism | JARID2 SPRED2 ATRX TRIO UBAP2L AFF3 DEPDC5 ASXL2 POGZ HERC1 CPLANE1 AHDC1 TRIM37 IL6ST | 4.69e-04 | 830 | 34 | 14 | HP:0000316 |
| HumanPheno | Pes planus | 4.73e-04 | 365 | 34 | 9 | HP:0001763 | |
| HumanPheno | Mandibular prognathia | 4.91e-04 | 219 | 34 | 7 | HP:0000303 | |
| HumanPheno | Restricted or repetitive behaviors or interests | 5.03e-04 | 368 | 34 | 9 | HP:0031432 | |
| HumanPheno | Abnormal location of ears | JARID2 SPRED2 ATRX UBAP2L AFF3 GATA4 DEPDC5 ASXL2 POGZ HERC1 CPLANE1 AHDC1 UNC80 IL6ST MADD | 5.15e-04 | 945 | 34 | 15 | HP:0000357 |
| HumanPheno | Perseverative thought | 6.01e-04 | 377 | 34 | 9 | HP:0030223 | |
| HumanPheno | Enlarged cisterna magna | 6.20e-04 | 60 | 34 | 4 | HP:0002280 | |
| HumanPheno | Mild myopia | 6.38e-04 | 6 | 34 | 2 | HP:0025573 | |
| HumanPheno | High forehead | 7.10e-04 | 306 | 34 | 8 | HP:0000348 | |
| HumanPheno | Disordered formal thought process | 7.14e-04 | 386 | 34 | 9 | HP:0025769 | |
| HumanPheno | Abnormality of the outer ear | CUL4B JARID2 SPRED2 ATRX TRIO UBAP2L AFF3 GATA4 DEPDC5 TSHZ1 ASXL2 POGZ HERC1 CPLANE1 AHDC1 UNC80 IL6ST MADD | 7.96e-04 | 1337 | 34 | 18 | HP:0000356 |
| HumanPheno | Abnormal eyebrow morphology | CUL4B JARID2 SPRED2 TRIO KMT5B UBAP2L AFF3 DEPDC5 ASXL2 HERC1 CPLANE1 MADD | 8.86e-04 | 674 | 34 | 12 | HP:0000534 |
| HumanPheno | Short neck | 8.92e-04 | 398 | 34 | 9 | HP:0000470 | |
| HumanPheno | Autistic behavior | JARID2 ATRX TRIO KMT5B UBAP2L AFF3 DEPDC5 CHD2 CNKSR2 POGZ AHDC1 MADD | 9.35e-04 | 678 | 34 | 12 | HP:0000729 |
| HumanPheno | Macrocephaly | CUL4B JARID2 TRIO KMT5B DEPDC5 ASXL2 HERC1 KMT2E TRIM37 IL6ST | 9.82e-04 | 491 | 34 | 10 | HP:0000256 |
| HumanPheno | Abnormal mandible morphology | CUL4B JARID2 SPRED2 ATRX TRIO UBAP2L AFF3 GATA4 ASXL2 POGZ HERC1 CPLANE1 AHDC1 UNC80 IL6ST MADD | 9.94e-04 | 1118 | 34 | 16 | HP:0000277 |
| HumanPheno | Abnormal thought pattern | 9.94e-04 | 404 | 34 | 9 | HP:5200269 | |
| HumanPheno | Abnormality of globe location | JARID2 SPRED2 ATRX TRIO UBAP2L AFF3 GATA4 DEPDC5 ASXL2 POGZ HERC1 KMT2E CPLANE1 AHDC1 TRIM37 IL6ST | 1.04e-03 | 1122 | 34 | 16 | HP:0100886 |
| HumanPheno | Chronic constipation | 1.07e-03 | 120 | 34 | 5 | HP:0012450 | |
| HumanPheno | Abnormality of globe location or size | JARID2 SPRED2 ATRX TRIO UBAP2L AFF3 GATA4 DEPDC5 CHD2 ASXL2 POGZ HERC1 KMT2E CPLANE1 AHDC1 TRIM37 IL6ST | 1.08e-03 | 1246 | 34 | 17 | HP:0000489 |
| HumanPheno | Abnormal lip morphology | CUL4B JARID2 SPRED2 ATRX TRIO UBAP2L AFF3 GATA4 CHD2 ASXL2 POGZ CPLANE1 ENG UNC80 KNG1 IL6ST MADD | 1.12e-03 | 1249 | 34 | 17 | HP:0000159 |
| HumanPheno | Increased head circumference | CUL4B JARID2 TRIO KMT5B DEPDC5 ASXL2 HERC1 KMT2E TRIM37 IL6ST | 1.13e-03 | 500 | 34 | 10 | HP:0040194 |
| HumanPheno | Short philtrum | 1.16e-03 | 253 | 34 | 7 | HP:0000322 | |
| HumanPheno | Absent frontal sinuses | 1.18e-03 | 8 | 34 | 2 | HP:0002688 | |
| HumanPheno | Upslanted palpebral fissure | 1.24e-03 | 333 | 34 | 8 | HP:0000582 | |
| HumanPheno | Impairment in personality functioning | CUL4B JARID2 PER3 ATRX TRIO KMT5B UBAP2L GATA4 IQSEC1 DEPDC5 CHD2 CNKSR2 POGZ KMT2E UNC80 MADD | 1.25e-03 | 1141 | 34 | 16 | HP:0031466 |
| HumanPheno | Abnormal external nose morphology | CUL4B JARID2 ATRX TRIO KMT5B UBAP2L AFF3 CHD2 ASXL2 POGZ CPLANE1 UNC80 IL6ST MADD | 1.31e-03 | 916 | 34 | 14 | HP:0010938 |
| HumanPheno | Reduced impulse control | CUL4B JARID2 ATRX TRIO KMT5B UBAP2L GATA4 IQSEC1 DEPDC5 CHD2 CNKSR2 POGZ KMT2E UNC80 MADD | 1.35e-03 | 1032 | 34 | 15 | HP:5200045 |
| HumanPheno | Abnormality of the palmar creases | 1.36e-03 | 260 | 34 | 7 | HP:0010490 | |
| HumanPheno | Thin upper lip vermilion | 1.39e-03 | 339 | 34 | 8 | HP:0000219 | |
| HumanPheno | Thin lips | 1.39e-03 | 339 | 34 | 8 | HP:0000213 | |
| HumanPheno | Short attention span | JARID2 TRIO KMT5B UBAP2L GATA4 IQSEC1 DEPDC5 CHD2 CNKSR2 MADD | 1.47e-03 | 517 | 34 | 10 | HP:0000736 |
| MousePheno | abnormal prenatal body size | TRPM6 CUL4B JARID2 TRIO UBR5 UBAP2L VCAN AFF3 GATA4 AFDN RICTOR FHOD3 TMEM131 CHD2 POGZ ENG SUCO AHDC1 IL6ST | 5.64e-06 | 1116 | 76 | 19 | MP:0010866 |
| MousePheno | ventricular septal defect | 1.15e-05 | 261 | 76 | 9 | MP:0010402 | |
| MousePheno | delayed heart looping | 1.27e-05 | 9 | 76 | 3 | MP:0009328 | |
| MousePheno | lethality throughout fetal growth and development, incomplete penetrance | 1.66e-05 | 208 | 76 | 8 | MP:0011109 | |
| MousePheno | lethality throughout fetal growth and development | TRPM6 CUL4B JARID2 HEG1 TRIO VCAN GATA4 RICTOR CHD2 POGZ IL6ST | 2.16e-05 | 435 | 76 | 11 | MP:0006208 |
| MousePheno | abnormal heart development | 3.15e-05 | 372 | 76 | 10 | MP:0000267 | |
| MousePheno | decreased fetal size | 3.32e-05 | 229 | 76 | 8 | MP:0004200 | |
| MousePheno | abnormal fetal size | 4.24e-05 | 237 | 76 | 8 | MP:0004198 | |
| MousePheno | abnormal fetal growth/weight/body size | 4.70e-05 | 312 | 76 | 9 | MP:0004197 | |
| MousePheno | embryonic lethality during organogenesis | TRPM6 CUL4B JARID2 NRG1 HEG1 ATRX KLF6 UBR5 VCAN GATA4 AFDN RICTOR FHOD3 POGZ ENG | 6.20e-05 | 876 | 76 | 15 | MP:0006207 |
| MousePheno | abnormal axial skeleton morphology | TRPM6 JARID2 CSRNP1 KLHL5 TTC28 KMT5B JADE2 DSPP AFF3 SKIDA1 CIR1 CHD2 TSHZ1 ASXL2 CPLANE1 ENG SUCO HECTD1 TRIM37 EMSY | 7.20e-05 | 1458 | 76 | 20 | MP:0002114 |
| MousePheno | abnormal cardiovascular development | JARID2 NRG1 HEG1 KLF6 UBR5 VCAN GATA4 CIR1 FHOD3 CCDC160 CPLANE1 ENG AHDC1 IL6ST | 9.23e-05 | 802 | 76 | 14 | MP:0002925 |
| MousePheno | abnormal interventricular septum morphology | 9.51e-05 | 342 | 76 | 9 | MP:0000281 | |
| MousePheno | abnormal prenatal growth/weight/body size | TRPM6 CUL4B JARID2 TRIO UBR5 UBAP2L VCAN AFF3 GATA4 AFDN RICTOR FHOD3 TMEM131 CHD2 POGZ CPLANE1 ENG SUCO AHDC1 IL6ST | 1.00e-04 | 1493 | 76 | 20 | MP:0004196 |
| MousePheno | abnormal pulmonary valve morphology | 1.02e-04 | 45 | 76 | 4 | MP:0002748 | |
| MousePheno | abnormal fluid regulation | JARID2 HEG1 UBR5 GATA4 CIR1 RICTOR FHOD3 TMEM131 CHD2 CPLANE1 ENG PRG4 TRIM37 IL6ST | 1.26e-04 | 826 | 76 | 14 | MP:0001784 |
| MousePheno | abnormal vertebrae morphology | TRPM6 TTC28 KMT5B AFF3 SKIDA1 CIR1 TSHZ1 ASXL2 CPLANE1 ENG EMSY | 1.67e-04 | 546 | 76 | 11 | MP:0000137 |
| MousePheno | abnormal synaptic transmission | NRG1 ATRX TTC28 JADE2 IQSEC1 AFDN UNC13C CHD2 POGZ IGSF11 SIPA1L2 CHRM2 CHRM4 UNC80 IL6ST MADD | 1.68e-04 | 1070 | 76 | 16 | MP:0003635 |
| MousePheno | abnormal synaptic physiology | NRG1 ATRX TTC28 JADE2 IQSEC1 AFDN UNC13C CHD2 POGZ IGSF11 SIPA1L2 CHRM2 CHRM4 UNC80 IL6ST MADD | 1.79e-04 | 1076 | 76 | 16 | MP:0021009 |
| MousePheno | abnormal heart right ventricle outflow tract morphology | 1.93e-04 | 53 | 76 | 4 | MP:0010428 | |
| MousePheno | abnormal pericardium morphology | 2.17e-04 | 225 | 76 | 7 | MP:0000288 | |
| MousePheno | abnormal heart septum morphology | 2.46e-04 | 388 | 76 | 9 | MP:0006113 | |
| MousePheno | abnormal heart atrium morphology | 2.62e-04 | 232 | 76 | 7 | MP:0003105 | |
| MousePheno | abnormal appendicular skeleton morphology | JARID2 CSRNP1 SPRED2 TTC28 JADE2 UBAP2L AFF3 CHD2 TSHZ1 CPLANE1 SUCO PRG4 EMSY IL6ST | 2.94e-04 | 896 | 76 | 14 | MP:0009250 |
| MousePheno | perinatal lethality | JARID2 NRG1 TRIO KMT5B KIF26B VCAN GATA4 TSHZ1 KMT2E SUCO HECTD1 AHDC1 UNC80 IL6ST MADD NR1D2 | 3.14e-04 | 1130 | 76 | 16 | MP:0002081 |
| MousePheno | abnormal heart ventricle morphology | JARID2 NRG1 HEG1 VCAN GATA4 CIR1 POGZ CPLANE1 ENG HECTD1 TRIM37 IL6ST NR1D2 | 3.14e-04 | 793 | 76 | 13 | MP:0005294 |
| MousePheno | embryonic lethality during organogenesis, complete penetrance | CUL4B JARID2 NRG1 ATRX KLF6 UBR5 VCAN GATA4 AFDN RICTOR FHOD3 ENG | 3.68e-04 | 700 | 76 | 12 | MP:0011098 |
| MousePheno | perinatal lethality, complete penetrance | JARID2 NRG1 TRIO KMT5B VCAN TSHZ1 SUCO HECTD1 AHDC1 UNC80 IL6ST MADD | 4.29e-04 | 712 | 76 | 12 | MP:0011089 |
| MousePheno | abnormal synovial joint morphology | 5.66e-04 | 124 | 76 | 5 | MP:0030804 | |
| MousePheno | joint swelling | 6.02e-04 | 7 | 76 | 2 | MP:0002936 | |
| MousePheno | delayed heart development | 6.84e-04 | 32 | 76 | 3 | MP:0012082 | |
| MousePheno | abnormal CNS synaptic transmission | NRG1 ATRX TTC28 JADE2 IQSEC1 AFDN UNC13C CHD2 POGZ IGSF11 SIPA1L2 CHRM2 CHRM4 MADD | 7.61e-04 | 985 | 76 | 14 | MP:0002206 |
| MousePheno | abnormal heart looping | 8.32e-04 | 135 | 76 | 5 | MP:0000269 | |
| Domain | Musac_Ach_rcpt | 2.33e-04 | 5 | 91 | 2 | IPR000995 | |
| Domain | HECT | 3.01e-04 | 27 | 91 | 3 | PF00632 | |
| Domain | HECTc | 3.01e-04 | 27 | 91 | 3 | SM00119 | |
| Domain | HECT_dom | 3.01e-04 | 27 | 91 | 3 | IPR000569 | |
| Domain | HECT | 3.01e-04 | 27 | 91 | 3 | PS50237 | |
| Domain | SUN_dom | 4.85e-04 | 7 | 91 | 2 | IPR012919 | |
| Domain | Sad1_UNC | 4.85e-04 | 7 | 91 | 2 | PF07738 | |
| Domain | ZF_PHD_2 | 1.20e-03 | 95 | 91 | 4 | PS50016 | |
| Domain | ZF_PHD_1 | 1.24e-03 | 96 | 91 | 4 | PS01359 | |
| Domain | GATA_ZN_FINGER_1 | 2.70e-03 | 16 | 91 | 2 | PS00344 | |
| Domain | GATA_ZN_FINGER_2 | 2.70e-03 | 16 | 91 | 2 | PS50114 | |
| Domain | MAGE_N | 4.21e-03 | 20 | 91 | 2 | SM01392 | |
| Domain | DS_RBD | 4.64e-03 | 21 | 91 | 2 | PS50137 | |
| Domain | PDZ | 5.01e-03 | 141 | 91 | 4 | PF00595 | |
| Domain | MAGE_N | 5.09e-03 | 22 | 91 | 2 | PF12440 | |
| Domain | - | 5.09e-03 | 22 | 91 | 2 | 2.130.10.30 | |
| Domain | MAGE_N | 5.09e-03 | 22 | 91 | 2 | IPR021072 | |
| Domain | RCC1/BLIP-II | 5.56e-03 | 23 | 91 | 2 | IPR009091 | |
| Domain | PDZ | 5.94e-03 | 148 | 91 | 4 | SM00228 | |
| Domain | - | 6.22e-03 | 150 | 91 | 4 | 2.30.42.10 | |
| Domain | PDZ | 6.37e-03 | 151 | 91 | 4 | PS50106 | |
| Pathway | WP_ENDODERM_DIFFERENTIATION | 3.13e-05 | 143 | 60 | 6 | M39591 | |
| Pathway | REACTOME_MUSCARINIC_ACETYLCHOLINE_RECEPTORS | 1.77e-04 | 5 | 60 | 2 | M27300 | |
| Pathway | REACTOME_MUSCARINIC_ACETYLCHOLINE_RECEPTORS | 1.77e-04 | 5 | 60 | 2 | MM15006 | |
| Pathway | KEGG_UBIQUITIN_MEDIATED_PROTEOLYSIS | 2.68e-04 | 135 | 60 | 5 | M15247 | |
| Pathway | WP_MONOAMINE_GPCRS | 3.03e-04 | 31 | 60 | 3 | MM15871 | |
| Pathway | WP_MONOAMINE_GPCRS | 3.65e-04 | 33 | 60 | 3 | M39585 | |
| Pathway | WP_MESODERMAL_COMMITMENT_PATHWAY | 4.76e-04 | 153 | 60 | 5 | M39546 | |
| Pubmed | TTC28 KIAA0513 UBR5 UBAP2L NAV3 CNKSR2 ASXL2 POGZ SIPA1L2 MADD | 1.33e-07 | 407 | 92 | 10 | 12693553 | |
| Pubmed | TRPM6 ZFAND3 KLHL5 ATRX UBAP2L VCAN RICTOR TMEM131 CHD2 ASXL2 HERC1 CPLANE1 SUCO TRIM37 MADD | 1.61e-07 | 1084 | 92 | 15 | 11544199 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | CUL4B ATRX UBAP2L IQSEC1 AFDN RICTOR POGZ SSRP1 ATAD2 PRG4 ZHX1 EMSY | 9.67e-07 | 774 | 92 | 12 | 15302935 |
| Pubmed | SPRED2 ATRX TTC28 TRIO NECAB1 JADE2 USP28 NAV3 AFDN TMEM131 POGZ HECTD1 TRIM37 MADD NR1D2 | 1.37e-06 | 1285 | 92 | 15 | 35914814 | |
| Pubmed | 1.45e-06 | 209 | 92 | 7 | 36779422 | ||
| Pubmed | BMI1-UBR5 axis regulates transcriptional repression at damaged chromatin. | 5.03e-06 | 13 | 92 | 3 | 27647897 | |
| Pubmed | Muscarinic M2 receptors on peripheral nerve endings: a molecular target of antinociception. | 6.92e-06 | 2 | 92 | 2 | 12045234 | |
| Pubmed | 6.92e-06 | 2 | 92 | 2 | 16365281 | ||
| Pubmed | 6.92e-06 | 2 | 92 | 2 | 10688600 | ||
| Pubmed | 6.92e-06 | 2 | 92 | 2 | 32265261 | ||
| Pubmed | Incorporating Functional Information in Tests of Excess De Novo Mutational Load. | 6.92e-06 | 2 | 92 | 2 | 26235986 | |
| Pubmed | 6.92e-06 | 2 | 92 | 2 | 36803960 | ||
| Pubmed | 6.92e-06 | 2 | 92 | 2 | 18550768 | ||
| Pubmed | 6.92e-06 | 2 | 92 | 2 | 11880500 | ||
| Pubmed | 6.92e-06 | 2 | 92 | 2 | 12235238 | ||
| Pubmed | 6.92e-06 | 2 | 92 | 2 | 26025056 | ||
| Pubmed | 6.92e-06 | 2 | 92 | 2 | 20203199 | ||
| Pubmed | 6.92e-06 | 2 | 92 | 2 | 12391271 | ||
| Pubmed | Generation and pharmacological analysis of M2 and M4 muscarinic receptor knockout mice. | 6.92e-06 | 2 | 92 | 2 | 11392613 | |
| Pubmed | 6.92e-06 | 2 | 92 | 2 | 24807965 | ||
| Pubmed | 6.92e-06 | 2 | 92 | 2 | 24807966 | ||
| Pubmed | 6.92e-06 | 2 | 92 | 2 | 12874603 | ||
| Pubmed | 6.92e-06 | 2 | 92 | 2 | 22956788 | ||
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | 1.92e-05 | 430 | 92 | 8 | 35044719 | |
| Pubmed | 2.07e-05 | 3 | 92 | 2 | 10485923 | ||
| Pubmed | 2.07e-05 | 3 | 92 | 2 | 28442355 | ||
| Pubmed | 2.07e-05 | 3 | 92 | 2 | 11961069 | ||
| Pubmed | Group II muscarinic acetylcholine receptors attenuate hepatic injury via Nrf2/ARE pathway. | 2.07e-05 | 3 | 92 | 2 | 32234387 | |
| Pubmed | 2.07e-05 | 3 | 92 | 2 | 17008557 | ||
| Pubmed | Destabilizing LSD1 by Jade-2 promotes neurogenesis: an antibraking system in neural development. | 2.07e-05 | 3 | 92 | 2 | 25018020 | |
| Pubmed | 2.07e-05 | 3 | 92 | 2 | 26850053 | ||
| Pubmed | 2.07e-05 | 3 | 92 | 2 | 18282687 | ||
| Pubmed | 2.07e-05 | 3 | 92 | 2 | 19478075 | ||
| Pubmed | Paradoxical sleep in mice lacking M3 and M2/M4 muscarinic receptors. | 2.07e-05 | 3 | 92 | 2 | 16110248 | |
| Pubmed | 2.07e-05 | 3 | 92 | 2 | 17878406 | ||
| Pubmed | Genetic deletion of CB1 receptors improves non-associative learning. | 2.07e-05 | 3 | 92 | 2 | 15922076 | |
| Pubmed | Differential role of MyD88 and Mal/TIRAP in TLR2-mediated gastric tumourigenesis. | 2.07e-05 | 3 | 92 | 2 | 23728346 | |
| Pubmed | 2.07e-05 | 3 | 92 | 2 | 15965496 | ||
| Pubmed | 2.50e-05 | 446 | 92 | 8 | 24255178 | ||
| Pubmed | 3.56e-05 | 469 | 92 | 8 | 27634302 | ||
| Pubmed | CUL4B TTC28 UBR5 KMT5B GATA4 IQSEC1 CRNN RICTOR POGZ SSRP1 SIPA1L2 UNC80 | 3.84e-05 | 1116 | 92 | 12 | 31753913 | |
| Pubmed | 4.14e-05 | 4 | 92 | 2 | 18382674 | ||
| Pubmed | Muscarinic regulation of dopamine and glutamate transmission in the nucleus accumbens. | 4.14e-05 | 4 | 92 | 2 | 26080439 | |
| Pubmed | 4.14e-05 | 4 | 92 | 2 | 15542826 | ||
| Pubmed | 4.14e-05 | 4 | 92 | 2 | 11855742 | ||
| Pubmed | Muscarinic receptor subtypes. Physiology and clinical implications. | 4.14e-05 | 4 | 92 | 2 | 2674717 | |
| Pubmed | 4.14e-05 | 4 | 92 | 2 | 2739737 | ||
| Pubmed | 4.14e-05 | 4 | 92 | 2 | 17851256 | ||
| Pubmed | 4.14e-05 | 4 | 92 | 2 | 9603968 | ||
| Pubmed | Identification of a family of muscarinic acetylcholine receptor genes. | 4.14e-05 | 4 | 92 | 2 | 3037705 | |
| Pubmed | 4.14e-05 | 4 | 92 | 2 | 15147302 | ||
| Pubmed | 4.14e-05 | 4 | 92 | 2 | 12433697 | ||
| Pubmed | 4.14e-05 | 4 | 92 | 2 | 8576254 | ||
| Pubmed | 4.14e-05 | 4 | 92 | 2 | 22042093 | ||
| Pubmed | 4.14e-05 | 4 | 92 | 2 | 3443095 | ||
| Pubmed | 4.14e-05 | 4 | 92 | 2 | 18206430 | ||
| Pubmed | System-Wide Modulation of HECT E3 Ligases with Selective Ubiquitin Variant Probes. | 4.46e-05 | 26 | 92 | 3 | 26949039 | |
| Pubmed | 4.76e-05 | 634 | 92 | 9 | 34591612 | ||
| Pubmed | 6.89e-05 | 5 | 92 | 2 | 20940295 | ||
| Pubmed | 6.89e-05 | 5 | 92 | 2 | 26084221 | ||
| Pubmed | 6.89e-05 | 5 | 92 | 2 | 15919709 | ||
| Pubmed | 6.89e-05 | 5 | 92 | 2 | 12675128 | ||
| Pubmed | IL-6 trans-signaling modulates TLR4-dependent inflammatory responses via STAT3. | 6.89e-05 | 5 | 92 | 2 | 21148800 | |
| Pubmed | Regulation of CD8+ cytolytic T lymphocyte differentiation by a cholinergic pathway. | 6.89e-05 | 5 | 92 | 2 | 15913791 | |
| Pubmed | Muscarinic acetylcholine receptor subtypes: localization and structure/function. | 6.89e-05 | 5 | 92 | 2 | 8248499 | |
| Pubmed | 6.89e-05 | 5 | 92 | 2 | 30914695 | ||
| Pubmed | 6.89e-05 | 5 | 92 | 2 | 15661360 | ||
| Pubmed | 6.89e-05 | 5 | 92 | 2 | 24695732 | ||
| Pubmed | 6.89e-05 | 5 | 92 | 2 | 7648406 | ||
| Pubmed | 6.89e-05 | 5 | 92 | 2 | 28425671 | ||
| Pubmed | 6.89e-05 | 5 | 92 | 2 | 15574798 | ||
| Pubmed | 6.89e-05 | 5 | 92 | 2 | 11306684 | ||
| Pubmed | 6.89e-05 | 5 | 92 | 2 | 20197056 | ||
| Pubmed | 6.89e-05 | 5 | 92 | 2 | 12151512 | ||
| Pubmed | Muscarinic receptors 2 and 5 regulate bitter response of urethral brush cells via negative feedback. | 6.89e-05 | 5 | 92 | 2 | 29401598 | |
| Pubmed | Muscarinic receptor subtypes in cilia-driven transport and airway epithelial development. | 6.89e-05 | 5 | 92 | 2 | 19213795 | |
| Pubmed | 6.89e-05 | 5 | 92 | 2 | 18755247 | ||
| Pubmed | 6.89e-05 | 5 | 92 | 2 | 27223629 | ||
| Pubmed | 6.89e-05 | 5 | 92 | 2 | 20463237 | ||
| Pubmed | 6.89e-05 | 5 | 92 | 2 | 19940190 | ||
| Pubmed | 7.63e-05 | 31 | 92 | 3 | 16554359 | ||
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | CUL4B TTC28 TRIO UBR5 AFDN TMEM131 SIPA1L2 CPLANE1 TRIM37 EMSY | 8.79e-05 | 853 | 92 | 10 | 28718761 |
| Pubmed | 9.23e-05 | 33 | 92 | 3 | 31143371 | ||
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | TTC28 TRIO KIF26B IQSEC1 AFDN RICTOR SSRP1 SIPA1L2 HECTD1 MADD | 9.49e-05 | 861 | 92 | 10 | 36931259 |
| Pubmed | 1.03e-04 | 6 | 92 | 2 | 11526399 | ||
| Pubmed | Monoubiquitination of ASXLs controls the deubiquitinase activity of the tumor suppressor BAP1. | 1.03e-04 | 6 | 92 | 2 | 30349006 | |
| Pubmed | 1.03e-04 | 6 | 92 | 2 | 27339059 | ||
| Pubmed | 1.03e-04 | 6 | 92 | 2 | 31914675 | ||
| Pubmed | Cardiac-specific developmental and epigenetic functions of Jarid2 during embryonic development. | 1.20e-04 | 36 | 92 | 3 | 29891551 | |
| Pubmed | Genome-wide association study meta-analysis identifies seven new rheumatoid arthritis risk loci. | 1.30e-04 | 37 | 92 | 3 | 20453842 | |
| Pubmed | GATA4/FOG2 transcriptional complex regulates Lhx9 gene expression in murine heart development. | 1.44e-04 | 7 | 92 | 2 | 18577233 | |
| Pubmed | 1.44e-04 | 7 | 92 | 2 | 23297343 | ||
| Pubmed | Endoglin integrates BMP and Wnt signalling to induce haematopoiesis through JDP2. | 1.44e-04 | 7 | 92 | 2 | 27713415 | |
| Pubmed | 1.44e-04 | 7 | 92 | 2 | 35427599 | ||
| Pubmed | Dynamic microtubules catalyze formation of navigator-TRIO complexes to regulate neurite extension. | 1.44e-04 | 7 | 92 | 2 | 25065758 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | HEG1 SPRED2 TRIO KIAA0513 DEPDC5 HERC1 SIPA1L2 HECTD1 CHRM4 AHDC1 MADD | 1.63e-04 | 1105 | 92 | 11 | 35748872 |
| Pubmed | mTORC1 signaling requires proteasomal function and the involvement of CUL4-DDB1 ubiquitin E3 ligase. | 1.92e-04 | 8 | 92 | 2 | 18235224 | |
| Pubmed | 2.05e-04 | 43 | 92 | 3 | 33472061 | ||
| Pubmed | LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy. | 2.05e-04 | 202 | 92 | 5 | 33005030 | |
| Pubmed | TRIO KIAA0513 CAMKV UBAP2L NAV3 IQSEC1 AFDN RICTOR CNKSR2 SIPA1L2 MADD | 2.11e-04 | 1139 | 92 | 11 | 36417873 | |
| Interaction | GSK3A interactions | CUL4B FAM193A TTC28 TRIO UBR5 KIF26B RICTOR SIPA1L2 HECTD1 ZC3H6 AHDC1 | 7.72e-06 | 464 | 91 | 11 | int:GSK3A |
| GeneFamily | Cholinergic receptors muscarinic | 1.15e-04 | 5 | 62 | 2 | 180 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | 1.18e-03 | 15 | 62 | 2 | 529 | |
| GeneFamily | PDZ domain containing | 1.83e-03 | 152 | 62 | 4 | 1220 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 2.26e-03 | 161 | 62 | 4 | 593 | |
| GeneFamily | CD molecules|Mucins | 2.33e-03 | 21 | 62 | 2 | 648 | |
| Coexpression | GSE40068_BCL6_POS_VS_NEG_CXCR5_POS_TFH_DN | 3.68e-08 | 200 | 92 | 9 | M9260 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | JARID2 NRG1 HEG1 FAM193A UBE2E1 SPRED2 ATRX TTC28 TRIO KLF6 UBR5 NAV3 TMEM131 SUCO AHDC1 TRIM37 | 4.52e-08 | 856 | 92 | 16 | M4500 |
| Coexpression | RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN | CSRNP1 PER3 KLF6 KMT5B RNF141 AFDN CHD2 TSHZ1 POGZ NOPCHAP1 HERC1 HECTD1 NR1D2 | 4.81e-06 | 807 | 92 | 13 | M16651 |
| Coexpression | RIGGI_EWING_SARCOMA_PROGENITOR_DN | 6.01e-06 | 196 | 92 | 7 | M13256 | |
| Coexpression | DAZARD_RESPONSE_TO_UV_NHEK_DN | 1.09e-05 | 300 | 92 | 8 | M8702 | |
| Coexpression | LIAO_HAVE_SOX4_BINDING_SITES | 1.30e-05 | 41 | 92 | 4 | M15025 | |
| Coexpression | AMIT_EGF_RESPONSE_40_HELA | 1.44e-05 | 42 | 92 | 4 | M4204 | |
| Coexpression | MURARO_PANCREAS_BETA_CELL | PER3 ATRX IQSEC1 TSHZ1 IGSF11 SIPA1L2 SUCO HECTD1 ZC3H6 TRIM37 UNC80 MADD NR1D2 | 2.59e-05 | 946 | 92 | 13 | M39169 |
| Coexpression | LAKE_ADULT_KIDNEY_C4_PROXIMAL_TUBULE_EPITHELIAL_CELLS_S2 | 3.72e-05 | 176 | 92 | 6 | M39223 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN | 3.87e-05 | 466 | 92 | 9 | M13522 | |
| Coexpression | BLANCO_MELO_COVID19_SARS_COV_2_INFECTION_A594_ACE2_EXPRESSING_CELLS_RUXOLITINIB_UP | 5.35e-05 | 486 | 92 | 9 | M34018 | |
| Coexpression | BLANCO_MELO_BETA_INTERFERON_TREATED_BRONCHIAL_EPITHELIAL_CELLS_UP | 5.63e-05 | 378 | 92 | 8 | M34022 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C6_MUC16_POS_CILIATED_CELL | 6.78e-05 | 62 | 92 | 4 | M45790 | |
| Coexpression | GSE5142_HTERT_TRANSDUCED_VS_CTRL_CD8_TCELL_LATE_PASSAGE_CLONE_DN | 7.57e-05 | 200 | 92 | 6 | M6552 | |
| Coexpression | NAKAYA_PBMC_FLUMIST_AGE_18_50YO_3DY_DN | 1.38e-04 | 680 | 92 | 10 | M41089 | |
| CoexpressionAtlas | dev gonad_e13.5_M_GermCell_Oct_top-relative-expression-ranked_1000 | CUL4B CCDC73 UBR5 USP28 CDKN2AIP RICTOR MAGEB16 NOPCHAP1 HERC1 CPLANE1 ATAD2 ZC3H6 TRIM37 NR1D2 | 8.64e-06 | 810 | 91 | 14 | gudmap_dev gonad_e13.5_M_GermCell_Oct_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_k-means-cluster#2_top-relative-expression-ranked_1000 | 1.54e-05 | 73 | 91 | 5 | gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_1000_k2 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle_emap-6706_top-relative-expression-ranked_1000 | FAM193A SPRED2 KIF26B VCAN NAV3 TSHZ1 ASXL2 KMT2E CPLANE1 SUCO ZC3H6 KNG1 IL6ST | 2.36e-05 | 769 | 91 | 13 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle_1000 |
| CoexpressionAtlas | DevelopingGonad_e14.5_ ovary_emap-6699_top-relative-expression-ranked_1000 | HEG1 PER3 ATRX UBAP2L GATA4 RICTOR DEPDC5 CHD2 ASXL2 HERC1 KMT2E CPLANE1 MADD | 2.59e-05 | 776 | 91 | 13 | gudmap_developingGonad_e14.5_ ovary_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Mandibular Arch_top-relative-expression-ranked_2500_k-means-cluster#2 | KLHL5 ATRX TRIO UBAP2L CIR1 TMEM131 DEPDC5 CHD2 ASXL2 HECTD1 ZHX1 | 2.92e-05 | 564 | 91 | 11 | Facebase_RNAseq_e9.5_Mandibular Arch_2500_K2 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle_emap-6706_k-means-cluster#1_top-relative-expression-ranked_1000 | 3.25e-05 | 209 | 91 | 7 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle_1000_k1 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_cortic collect duct_emap-28132_k-means-cluster#4_top-relative-expression-ranked_1000 | 3.33e-05 | 375 | 91 | 9 | gudmap_developingKidney_e15.5_cortic collect duct_1000_k4 | |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_top-relative-expression-ranked_1000 | CUL4B KLHL5 HEG1 KIF26B VCAN AFF3 GATA4 MUC16 TSHZ1 CNKSR2 NOPCHAP1 TMC3 CHRM4 | 3.42e-05 | 797 | 91 | 13 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_k-means-cluster#5_top-relative-expression-ranked_500 | 4.40e-05 | 149 | 91 | 6 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_500_k5 | |
| CoexpressionAtlas | dev gonad_e13.5_F_MeioticGermCell_Oct_top-relative-expression-ranked_1000 | CUL4B CCDC73 USP28 RNF141 CNKSR2 MAGEB16 HERC1 CPLANE1 ATAD2 ZC3H6 TRIM37 MADD NR1D2 | 4.58e-05 | 820 | 91 | 13 | gudmap_dev gonad_e13.5_F_MeioticGermCell_Oct_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_top-relative-expression-ranked_2500_k-means-cluster#4 | CUL4B KLHL5 ATRX TRIO CIR1 DEPDC5 CHD2 ASXL2 SSRP1 HECTD1 TRIM37 | 4.74e-05 | 595 | 91 | 11 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_2500_K4 |
| CoexpressionAtlas | dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_k-means-cluster#4_top-relative-expression-ranked_500 | 5.26e-05 | 94 | 91 | 5 | gudmap_dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_k4_500 | |
| CoexpressionAtlas | dev gonad_e12.5_F_SupCellPrec_Sry_top-relative-expression-ranked_500 | 7.14e-05 | 414 | 91 | 9 | gudmap_dev gonad_e12.5_F_SupCellPrec_Sry_500 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_k-means-cluster#2_top-relative-expression-ranked_500 | 9.75e-05 | 107 | 91 | 5 | gudmap_developingGonad_e14.5_ epididymis_500_k2 | |
| CoexpressionAtlas | dev gonad_e11.5_F_GonMes_Sma_top-relative-expression-ranked_500 | 1.06e-04 | 436 | 91 | 9 | gudmap_dev gonad_e11.5_F_GonMes_Sma_500 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_cortic collect duct_emap-28132_top-relative-expression-ranked_1000 | CUL4B UBE2E1 PER3 ATRX ASXL2 CCDC160 CPLANE1 SUCO ZC3H6 EIF2AK2 KNG1 IL6ST | 1.14e-04 | 774 | 91 | 12 | gudmap_developingKidney_e15.5_cortic collect duct_1000 |
| CoexpressionAtlas | kidney_P1_CapMes_Crym_top-relative-expression-ranked_100 | 1.46e-04 | 62 | 91 | 4 | gudmap_kidney_P1_CapMes_Crym_100 | |
| CoexpressionAtlas | dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_top-relative-expression-ranked_1000 | CUL4B KLHL5 HEG1 KIF26B VCAN AFF3 GATA4 MUC16 TSHZ1 CNKSR2 NOPCHAP1 CHRM4 | 1.49e-04 | 797 | 91 | 12 | gudmap_dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_1000 |
| CoexpressionAtlas | dev gonad_e13.5_F_MeioticGermCell_Oct_k-means-cluster#3_top-relative-expression-ranked_1000 | 1.54e-04 | 187 | 91 | 6 | gudmap_dev gonad_e13.5_F_MeioticGermCell_Oct_k3_1000 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_ovary_emap-28876_top-relative-expression-ranked_1000 | CUL4B HEG1 ATRX UBAP2L GATA4 RICTOR DEPDC5 CHD2 ASXL2 HERC1 KMT2E CPLANE1 | 1.62e-04 | 804 | 91 | 12 | gudmap_developingGonad_e12.5_ovary_1000 |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_k-means-cluster#3_top-relative-expression-ranked_1000 | 1.73e-04 | 191 | 91 | 6 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_k3_1000 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k-means-cluster#3_top-relative-expression-ranked_1000 | 1.87e-04 | 369 | 91 | 8 | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k3_1000 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle_emap-6706_k-means-cluster#3_top-relative-expression-ranked_1000 | 1.97e-04 | 67 | 91 | 4 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle_1000_k3 | |
| CoexpressionAtlas | dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_top-relative-expression-ranked_500 | 2.49e-04 | 385 | 91 | 8 | gudmap_dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_1000_k-means-cluster#3 | 2.56e-04 | 291 | 91 | 7 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_1000_K3 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_ovary_emap-9563_top-relative-expression-ranked_500 | 2.58e-04 | 387 | 91 | 8 | gudmap_developingGonad_e16.5_ovary_500 | |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_top-relative-expression-ranked_1000 | CUL4B KLHL5 HEG1 VCAN AFF3 GATA4 MUC16 TSHZ1 NOPCHAP1 TMC3 CHRM4 | 3.21e-04 | 740 | 91 | 11 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_1000 |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_top-relative-expression-ranked_500 | 3.55e-04 | 406 | 91 | 8 | gudmap_developingGonad_e16.5_epididymis_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_k-means-cluster#2_top-relative-expression-ranked_1000 | 3.90e-04 | 312 | 91 | 7 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_1000_k2 | |
| CoexpressionAtlas | dev gonad_e13.5_F_SupCellPrec_Sry_k-means-cluster#2_top-relative-expression-ranked_1000 | 3.98e-04 | 223 | 91 | 6 | gudmap_dev gonad_e13.5_F_SupCellPrec_Sry_k2_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Non-Floor Plate Neural Epithelium_top-relative-expression-ranked_500_k-means-cluster#1 | 4.02e-04 | 145 | 91 | 5 | Facebase_RNAseq_e8.5_Non-Floor Plate Neural Epithelium_500_K1 | |
| CoexpressionAtlas | dev gonad_e12.5_F_SupCellPrec_Sry_k-means-cluster#1_top-relative-expression-ranked_500 | 4.02e-04 | 145 | 91 | 5 | gudmap_dev gonad_e12.5_F_SupCellPrec_Sry_k1_500 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ ovary_emap-6699_k-means-cluster#3_top-relative-expression-ranked_1000 | 4.17e-04 | 225 | 91 | 6 | gudmap_developingGonad_e14.5_ ovary_1000_k3 | |
| CoexpressionAtlas | kidney_P2_CapMes_Crym_top-relative-expression-ranked_100 | 4.69e-04 | 84 | 91 | 4 | gudmap_kidney_P2_CapMes_Crym_100 | |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitTestis_Sma_top-relative-expression-ranked_200 | 5.14e-04 | 153 | 91 | 5 | gudmap_dev gonad_e12.5_M_InterstitTestis_Sma_200 | |
| CoexpressionAtlas | dev gonad_e11.5_M_GonMes_Sma_top-relative-expression-ranked_500 | 5.36e-04 | 432 | 91 | 8 | gudmap_dev gonad_e11.5_M_GonMes_Sma_500 | |
| CoexpressionAtlas | dev gonad_e13.5_M_GermCell_Oct_k-means-cluster#1_top-relative-expression-ranked_1000 | 5.74e-04 | 333 | 91 | 7 | gudmap_dev gonad_e13.5_M_GermCell_Oct_k1_1000 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_anlage of loop of Henle_emap-31283_top-relative-expression-ranked_1000 | FAM193A UBE2E1 ATRX FHOD3 ASXL2 CCDC160 ATAD2 SUCO EIF2AK2 ZHX1 KNG1 | 5.85e-04 | 795 | 91 | 11 | gudmap_developingKidney_e15.5_anlage of loop of Henle_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_top-relative-expression-ranked_1000 | ARHGAP6 FAM193A ATRX TRIO KIF26B VCAN ASXL2 CPLANE1 SUCO ZC3H6 IL6ST | 6.55e-04 | 806 | 91 | 11 | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_1000 |
| CoexpressionAtlas | DevelopingKidney_e15.5_Cap mesenchyme_emap-27738_k-means-cluster#4_top-relative-expression-ranked_1000 | 7.04e-04 | 164 | 91 | 5 | gudmap_developingKidney_e15.5_Cap mesenchyme_1000_k4 | |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitTestis_Sma_k-means-cluster#4_top-relative-expression-ranked_200 | 7.74e-04 | 42 | 91 | 3 | gudmap_dev gonad_e12.5_M_InterstitTestis_Sma_k4_200 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_ovary_emap-12283_k-means-cluster#3_top-relative-expression-ranked_500 | 8.07e-04 | 97 | 91 | 4 | gudmap_developingGonad_e18.5_ovary_500_k3 | |
| CoexpressionAtlas | kidney_P1_CapMes_Crym_k-means-cluster#4_top-relative-expression-ranked_100 | 8.30e-04 | 43 | 91 | 3 | gudmap_kidney_P1_CapMes_Crym_k4_100 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_100 | 8.71e-04 | 99 | 91 | 4 | Facebase_RNAseq_e8.5_Floor Plate_100 | |
| CoexpressionAtlas | dev gonad_e12.5_F_SupCellPrec_Sry_k-means-cluster#1_top-relative-expression-ranked_1000 | 8.72e-04 | 259 | 91 | 6 | gudmap_dev gonad_e12.5_F_SupCellPrec_Sry_k1_1000 | |
| CoexpressionAtlas | CD positive, CD4 Test JS, 4+8-B220-, Spleen, avg-3 | 8.93e-04 | 359 | 91 | 7 | GSM404000_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle M_emap-6706_M-2fold-vs-F_top305_305 | 1.00e-03 | 266 | 91 | 6 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle M_250_M-vs-F-2X | |
| ToppCell | COPD-Endothelial-VE_Capillary_B|Endothelial / Disease state, Lineage and Cell class | 7.96e-09 | 197 | 92 | 8 | 30dbc05ea66892d2e18ff375ffa86d1db7bc4083 | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 1.29e-07 | 188 | 92 | 7 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 | |
| ToppCell | human_hepatoblastoma-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 1.49e-07 | 192 | 92 | 7 | 916fbec1c7ab7969bda711886ac88e877e30c280 | |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6|TCGA-Prostate / Sample_Type by Project: Shred V9 | 1.54e-07 | 193 | 92 | 7 | abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659 | |
| ToppCell | human_hepatoblastoma|World / Sample and Cell Type and Tumor Cluster (all cells) | 1.54e-07 | 193 | 92 | 7 | e6a688bc834f845ff64dae1be64f073eec5091a1 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.60e-07 | 194 | 92 | 7 | e3d63874111d1e8da3977329426e4dcf68d6de87 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Lamp5-Lamp5_Plch2_Dock5|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 9.13e-07 | 157 | 92 | 6 | 516903469756c5fabfdf56d7bd59b3bdd7b44e39 | |
| ToppCell | COVID-19-kidney-PEC|kidney / Disease (COVID-19 only), tissue and cell type | 1.55e-06 | 172 | 92 | 6 | 36a96714a0eb6ac438648135336c9791881ddadb | |
| ToppCell | COVID-19-kidney-Epi_(Mes)|kidney / Disease (COVID-19 only), tissue and cell type | 1.96e-06 | 179 | 92 | 6 | e7c9dc63f03d3f3746b51a7e3c8393089e2ceb7d | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.09e-06 | 181 | 92 | 6 | 5f2d3a08577c440c944778d07aa993c6e7873f3d | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.09e-06 | 181 | 92 | 6 | c7c5f7d4c397b4613c772413a0a679377efffff3 | |
| ToppCell | COVID-19-Heart-EC_(POSTN)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.68e-06 | 189 | 92 | 6 | 7346c1112e2e155dbd71b6dbc80e680fd262a691 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.68e-06 | 189 | 92 | 6 | 3b48b0d220cc24d5170713d61fa91f5bb6c21841 | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.94e-06 | 192 | 92 | 6 | 04f5a2e3dd6beff027b89d66eefdd92036e041af | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.94e-06 | 192 | 92 | 6 | c07d7b40b2aa4eb27ac85801c014a656e2fd01dc | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.12e-06 | 194 | 92 | 6 | 011e14d9ed1393275f892060e7708ffadcd0767f | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 3.12e-06 | 194 | 92 | 6 | b1bb0f846d2865efdd9bc8842b16b9d069785882 | |
| ToppCell | LPS-IL1RA-Endothelial|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.12e-06 | 194 | 92 | 6 | 43f92b0533e26633dc94cce554045d641ef8fd76 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.12e-06 | 194 | 92 | 6 | 35f132cc38ac133be01834ed0946188aa0757eb4 | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.12e-06 | 194 | 92 | 6 | 1d39d968730a7e85b6161c1c8a6bd38afe9bcad7 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 3.21e-06 | 195 | 92 | 6 | 0e55fa5b3cbeb7baee3d4ac272a3bf80381ec937 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m-Neuronal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.21e-06 | 195 | 92 | 6 | ffbab350e67d9c4b66c0ab84550daec8b8139a27 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.21e-06 | 195 | 92 | 6 | 3e519cffa6144a62b06124642a14c9ff39b76554 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.21e-06 | 195 | 92 | 6 | 7796ea9247f4c63762f0de8490fed08b9717fa23 | |
| ToppCell | mild_COVID-19_(asymptomatic)|World / disease group, cell group and cell class (v2) | 3.31e-06 | 196 | 92 | 6 | 8cb3dcb3e5732f4bb060c87ca339b8997a1a8cd4 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 3.40e-06 | 197 | 92 | 6 | 0034bae02ee7fcfea520d453ca3c842ab6963b12 | |
| ToppCell | Parenchymal-NucSeq-Endothelial-Endothelia_vascular-VE_alveolar_capillary_Car4_aerocyte|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.61e-06 | 199 | 92 | 6 | dc88ce36cc066eb6c28cfd5b9b60fe07f8cc7b53 | |
| ToppCell | Tracheal-NucSeq|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations | 3.61e-06 | 199 | 92 | 6 | 94b94b17ca18b8dc27b91da1f2ccf89e03cc7035 | |
| ToppCell | Bronchial-NucSeq-Endothelial-Endothelia_vascular-VE_alveolar_capillary_Car4_aerocyte|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.71e-06 | 200 | 92 | 6 | 105c67e4f5eff036013d655c8e8ac577d32dae2e | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Lamp5-Lamp5_Ntn1_Npy2r|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.60e-05 | 152 | 92 | 5 | 8ff5a178a8f3550d89a003c0858820aab3773386 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Lamp5-Lamp5_Plch2_Dock5|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.60e-05 | 152 | 92 | 5 | fed80b467ec9e30c7f98bed6cc4f8c583b715e9e | |
| ToppCell | TCGA-Ovary-Primary_Tumor-Ovarian_Carcinoma-Serous_Cystadenocarcinoma-5|TCGA-Ovary / Sample_Type by Project: Shred V9 | 2.44e-05 | 166 | 92 | 5 | 32d2eaf8a5d03881bf74d680825af2d5110b082d | |
| ToppCell | 10x5'-bone_marrow-Lymphocytic_T_CD4-Tfh|bone_marrow / Manually curated celltypes from each tissue | 2.44e-05 | 166 | 92 | 5 | 9ac5267d3a53a96dec9eae3bc01acba4750742c8 | |
| ToppCell | BAL-Mild-Epithelial-Epithelial-AT1/AT2|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.06e-05 | 174 | 92 | 5 | b7f5492ce8098f7eb0aef30ee558d00738d59d0e | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT2_L6_FEZF2-Exc_L6_FEZF2_TBCC|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.06e-05 | 174 | 92 | 5 | 912a9e892b29d945666fc37c986009c97c668ac8 | |
| ToppCell | BAL-Mild-Epithelial-Epithelial-AT1/AT2-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 3.06e-05 | 174 | 92 | 5 | 71730503be3d9c839c4c9e950145e2101d682a1c | |
| ToppCell | BAL-Mild-Epithelial-Epithelial-AT1/AT2|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.06e-05 | 174 | 92 | 5 | ee8ac51fa0b426ad7b7453371bb79c8bf8c1d358 | |
| ToppCell | BAL-Mild-Epithelial-Epithelial-AT1/AT2-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.06e-05 | 174 | 92 | 5 | cafe4d6b5f08d8888e9db6e196c66df991c03e7b | |
| ToppCell | COVID-19-kidney-Epi_(Mes)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.41e-05 | 178 | 92 | 5 | 544379f5a6145429762258d426b876bb36c112f5 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_2|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.89e-05 | 183 | 92 | 5 | 2e831a4d99c6f983793df71c0994124c943c6da9 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.99e-05 | 184 | 92 | 5 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell__prolif|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.99e-05 | 184 | 92 | 5 | 688428103e8b19f45f2f65d70a0f30c904c8411c | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.99e-05 | 184 | 92 | 5 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_C_(IT_L4_RORB)|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.99e-05 | 184 | 92 | 5 | 6475a43201b136dcc9b113d2ca4cfa154ed9d65d | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.99e-05 | 184 | 92 | 5 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | facs-Heart-LA-18m-Endothelial-endocardial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.10e-05 | 185 | 92 | 5 | 1ecfca049c0c1110fd1b2256db7cb7abda6afb04 | |
| ToppCell | facs-Heart-LA-18m-Endothelial-endothelial_cell_of_endocardium|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.10e-05 | 185 | 92 | 5 | b6df1412b579d40ed5df806f9c54bd1fbb9a1e15 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.10e-05 | 185 | 92 | 5 | 34fcfd635c828dad9643bbf1c908d79282d6f5d9 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.10e-05 | 185 | 92 | 5 | 8816f2909ed11833ff3d0ed96b9cb6d6fe9e1578 | |
| ToppCell | droplet-Heart-nan-3m-Endothelial|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.21e-05 | 186 | 92 | 5 | 0ae5fbe9f210cb25092394267e1d3d6ed05627b8 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 4.21e-05 | 186 | 92 | 5 | b87acc80b7baa41681e4ed11d5537b9fbf5832f5 | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 4.21e-05 | 186 | 92 | 5 | 03db813598b67b1e08f759758a1c2023396921fa | |
| ToppCell | ILEUM-inflamed-(3)_MNP-(3)_moDC|(3)_MNP / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 4.31e-05 | 187 | 92 | 5 | 0099def970fbc828756fbf853eca2ce77b8cd342 | |
| ToppCell | Control-Endothelial_cells-Endothelial_cells_(general)|Control / group, cell type (main and fine annotations) | 4.31e-05 | 187 | 92 | 5 | fb5bcbc8effdbf0e57fcb71aca990a4aa0d65ce8 | |
| ToppCell | P03-Endothelial-large_vessel_endothelial_cell-endothelial_cell_of_vein|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 4.42e-05 | 188 | 92 | 5 | 5eb107122064f0a99dfd445cc87d3766f7257216 | |
| ToppCell | Children_(3_yrs)-Endothelial-capillary_endothelial_cell_(Cap1)-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.42e-05 | 188 | 92 | 5 | 117dc80fa940e6aa1b0187a43fdde33f3fcb578f | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.42e-05 | 188 | 92 | 5 | eec3d353e51358db4c7621265ee0fdd4298e5b0e | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.54e-05 | 189 | 92 | 5 | 977a813e5d7a5a561c1fced2bbf21c20056b88d8 | |
| ToppCell | RA-10._Endothelium_II|World / Chamber and Cluster_Paper | 4.54e-05 | 189 | 92 | 5 | 75c248b9de5e2fb7a0baa8cdbab516e575cc4394 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 4.65e-05 | 190 | 92 | 5 | 656483751e4bf137e4e4bfb2a03a478a8f7fcb63 | |
| ToppCell | Control-Endothelial-VE_Capillary_B|Endothelial / Disease state, Lineage and Cell class | 4.65e-05 | 190 | 92 | 5 | 7f3f419fffe02934b6f27b697f7a6401072491ed | |
| ToppCell | PND10|World / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.65e-05 | 190 | 92 | 5 | d67e2814047c8df2ae4b7bc8be9539f5df6ecef2 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.65e-05 | 190 | 92 | 5 | e252e925600e6457fa6e362a55217f4cffa75cdb | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.77e-05 | 191 | 92 | 5 | 1cb02007adb344f17ef73d58890f91298c7cf5a1 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.77e-05 | 191 | 92 | 5 | 107113b930d9ad171f1b2aa20df4567c94fae7d8 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.77e-05 | 191 | 92 | 5 | bc353a79a1d11ca52bba5e3874a80d432e1a7715 | |
| ToppCell | COVID-19-Heart-EC_(POSTN)|Heart / Disease (COVID-19 only), tissue and cell type | 4.89e-05 | 192 | 92 | 5 | c0c34785a7bdf461722029b322e9184e3d9b3c26 | |
| ToppCell | COVID-19-kidney-AQP1+PLVAP+EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.89e-05 | 192 | 92 | 5 | 27ff3621e177e7932dd44dd6baa81551ea75a874 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.89e-05 | 192 | 92 | 5 | 5105e4b577408b4e1a62d0a44c23c2b830ccad88 | |
| ToppCell | facs-Aorta-Heart-3m|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.89e-05 | 192 | 92 | 5 | 1ccc47792edf9ee23501c8e2165d11271636b66a | |
| ToppCell | renal_cortex_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | 4.89e-05 | 192 | 92 | 5 | e8cc4d08fcfceeab75a02558817e4ccd7dbafe3a | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.89e-05 | 192 | 92 | 5 | c0e59e642b42c055cf73d029cf54d07d9b719359 | |
| ToppCell | 10x5'-Lung-Myeloid_Monocytic|Lung / Manually curated celltypes from each tissue | 5.01e-05 | 193 | 92 | 5 | ebe6be10ef5de9e1da988e263106698d3db42fce | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m-Neuronal-neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.01e-05 | 193 | 92 | 5 | 461919ab422bc9d1fcff7a3a4757c75239041d7e | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.01e-05 | 193 | 92 | 5 | 0dd810ad900d3e586551622b2c1de39d76fd6a7f | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Activated_Alv_Cap|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.01e-05 | 193 | 92 | 5 | a3636c35ed25aabe2f1aba016c9fe125327bbfaf | |
| ToppCell | Posterior_cortex-Neuronal|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 5.01e-05 | 193 | 92 | 5 | b4989e3436e84dbec3789b46057e0f7a0ebf09d4 | |
| ToppCell | Mesenchymal-matrix_fibroblast_1_cell|World / Lineage, Cell type, age group and donor | 5.01e-05 | 193 | 92 | 5 | acad568621ed677031797b8c2e34dafea798d681 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.01e-05 | 193 | 92 | 5 | 52e918884877b6659cdca0496390e440f73694a9 | |
| ToppCell | Transplant_Alveoli_and_parenchyma-Immune-Neutrophils|Immune / Tissue, Lineage and Cell class of Lung Cells from 10X | 5.14e-05 | 194 | 92 | 5 | 28571cf24b8a1d0ffb716167b977d420868cc874 | |
| ToppCell | Children_(3_yrs)-Endothelial-capillary_endothelial_cell_(Cap1)|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.14e-05 | 194 | 92 | 5 | 71ac69cdf7a08ca3ddfb5b492b14ac56b6cd5e5d | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L3-5_SST_MAFB|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.14e-05 | 194 | 92 | 5 | 83863da11dfbe59b2d0a2c08db40b537c150588c | |
| ToppCell | IPF-Endothelial-VE_Capillary_A|Endothelial / Disease state, Lineage and Cell class | 5.14e-05 | 194 | 92 | 5 | 777ce41c3f22c591e2d81120f189b834e53ffb4b | |
| ToppCell | facs-Pancreas-Endocrine-18m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.26e-05 | 195 | 92 | 5 | bd8e24dd598990204998d1dd853ba7a53dc0107e | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.26e-05 | 195 | 92 | 5 | 2e1df01bf6e4e98e6cd9fb50926e34c5077b8666 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.39e-05 | 196 | 92 | 5 | ab7be3858deabbd1fc44e8b9da8ff49a50bf1fb1 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-Mono-Mono_hypoxia|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.39e-05 | 196 | 92 | 5 | a44a648bf209ce037bfc7b3adfcb220aab60728c | |
| ToppCell | COVID-19-lung-Capillary_Aerocytes|lung / Disease (COVID-19 only), tissue and cell type | 5.39e-05 | 196 | 92 | 5 | 4ac4073380d939a73cec7413e9f3f5ef616d2924 | |
| ToppCell | COVID-19-Fibroblasts|COVID-19 / group, cell type (main and fine annotations) | 5.52e-05 | 197 | 92 | 5 | fb847f2277609c31fffcdf49517243ce0684facf | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 5.52e-05 | 197 | 92 | 5 | 11a4c417f035e554431a8f03be13b5eefa3530c0 | |
| ToppCell | COVID-19-lung-Fibroblast|lung / Disease (COVID-19 only), tissue and cell type | 5.66e-05 | 198 | 92 | 5 | df3de77216f5c5d6141ec44d01c56b942f611838 | |
| ToppCell | Caecum-(6)_Macrophage-(61)_LYVE1_Macrophage|Caecum / shred on region, Cell_type, and subtype | 5.66e-05 | 198 | 92 | 5 | e684c3934c163aef4d284b69435832d2c9614f2a | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.66e-05 | 198 | 92 | 5 | 0a172c6d997c7cfbad34b56e80121bd104dee67d | |
| ToppCell | Caecum-Macrophage-LYVE1_Macrophage|Caecum / Region, Cell class and subclass | 5.66e-05 | 198 | 92 | 5 | a92c0cacb775aca6bbb302bd9e22c081a112a44d | |
| ToppCell | mild-HLA-DR-_S100A+_Monocyte|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 5.79e-05 | 199 | 92 | 5 | d0d286eafe935f9b3aaba5b783e8911251121b4a | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Epithelial-Epithelial,_Airway-squamous_epithelial_cell-Epi-Squamous|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.79e-05 | 199 | 92 | 5 | a8f4bd0e65f36b29535864fae4347369d5c864d2 | |
| ToppCell | 3'_v3-Lung-Myeloid_Monocytic-Classical_monocytes|Lung / Manually curated celltypes from each tissue | 5.79e-05 | 199 | 92 | 5 | bfd0d171ea6bb7abd5cdfeac22608cc190aaa2be | |
| ToppCell | distal-Hematologic-Classical_Monocyte-1|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 5.79e-05 | 199 | 92 | 5 | cd691f1c2493516d7553cc9a005f6e3b442bdbd5 | |
| ToppCell | Transverse-Macrophage-LYVE1_Macrophage|Transverse / Region, Cell class and subclass | 5.79e-05 | 199 | 92 | 5 | facf79c256db5ae57bdb613e86ec90616a6f67ca | |
| ToppCell | Transverse-(6)_Macrophage-(61)_LYVE1_Macrophage|Transverse / shred on region, Cell_type, and subtype | 5.79e-05 | 199 | 92 | 5 | dcc2a7f4d1fa30aaaad655dd59c5a2b039d264bf | |
| Drug | Brompheniramine | 1.27e-06 | 6 | 92 | 3 | DB00835 | |
| Drug | Benzquinamide | 1.27e-06 | 6 | 92 | 3 | DB00767 | |
| Drug | Maprotiline | 3.52e-06 | 8 | 92 | 3 | DB00934 | |
| Drug | Promethazine | 7.51e-06 | 10 | 92 | 3 | DB01069 | |
| Drug | Imipramine | 1.03e-05 | 11 | 92 | 3 | DB00458 | |
| Drug | Nortriptyline | 1.37e-05 | 12 | 92 | 3 | DB00540 | |
| Drug | Chlorprothixene | 1.37e-05 | 12 | 92 | 3 | DB01239 | |
| Drug | Guanabenz acetate [23256-50-0]; Up 200; 13.8uM; MCF7; HT_HG-U133A | 1.59e-05 | 198 | 92 | 7 | 1544_UP | |
| Drug | Mebeverine hydrochloride [2753-45-9]; Up 200; 8.6uM; MCF7; HT_HG-U133A | 1.59e-05 | 198 | 92 | 7 | 3193_UP | |
| Drug | Dimethindene | 1.62e-05 | 2 | 92 | 2 | DB08801 | |
| Drug | Loderix | 1.62e-05 | 2 | 92 | 2 | CID000043081 | |
| Drug | himbacine | 1.62e-05 | 2 | 92 | 2 | ctd:C048172 | |
| Drug | Desipramine | 1.77e-05 | 13 | 92 | 3 | DB01151 | |
| Drug | Promazine | 2.25e-05 | 14 | 92 | 3 | DB00420 | |
| Drug | Propiomazine | 2.25e-05 | 14 | 92 | 3 | DB00777 | |
| Drug | thiethylperazine | 2.80e-05 | 15 | 92 | 3 | CID000005440 | |
| Drug | PGW5 compound | 4.17e-05 | 17 | 92 | 3 | ctd:C000593032 | |
| Drug | BTM-1086 | 4.83e-05 | 3 | 92 | 2 | CID000126373 | |
| Drug | eburnamonine | 4.83e-05 | 3 | 92 | 2 | ctd:C016422 | |
| Drug | AH 7170 | 4.83e-05 | 3 | 92 | 2 | CID000191364 | |
| Drug | Amitriptyline | 4.99e-05 | 18 | 92 | 3 | DB00321 | |
| Drug | Methotrimeprazine | 5.90e-05 | 19 | 92 | 3 | DB01403 | |
| Drug | Doxepin | 6.92e-05 | 20 | 92 | 3 | DB01142 | |
| Drug | Air Pollutants | CUL4B NRG1 SYCP2L ZFAND3 TTC28 FPR1 VCAN NAV3 CIR1 AFDN CPLANE1 ZC3H6 NR1D2 | 7.92e-05 | 917 | 92 | 13 | ctd:D000393 |
| Drug | Chloroprene | DOCK5 KLHL5 FAM193A PER3 ATRX TRIO KLF6 JADE2 KIF26B AFF3 TSHZ1 POGZ KMT2E HECTD1 EMSY NR1D2 | 9.19e-05 | 1348 | 92 | 16 | ctd:D002737 |
| Drug | furtrethonium | 9.64e-05 | 4 | 92 | 2 | ctd:C028530 | |
| Drug | Hyoscyamine | 9.64e-05 | 4 | 92 | 2 | DB00424 | |
| Drug | Procyclidine | 9.64e-05 | 4 | 92 | 2 | DB00387 | |
| Drug | AHR-602 | 9.64e-05 | 4 | 92 | 2 | CID000065515 | |
| Drug | Tropicamide | 9.64e-05 | 4 | 92 | 2 | DB00809 | |
| Drug | 5-methylfurtrethonium | 9.64e-05 | 4 | 92 | 2 | ctd:C008446 | |
| Drug | DM-COOK | 9.64e-05 | 4 | 92 | 2 | CID000023606 | |
| Drug | palladium nitrate | 9.64e-05 | 4 | 92 | 2 | CID000024932 | |
| Drug | Fluocinonide [356-12-7]; Up 200; 8uM; PC3; HT_HG-U133A | 1.23e-04 | 190 | 92 | 6 | 4314_UP | |
| Drug | Prednicarbate [73771-04-7]; Down 200; 8.2uM; PC3; HT_HG-U133A | 1.34e-04 | 193 | 92 | 6 | 5119_DN | |
| Drug | Olanzapine | 1.38e-04 | 25 | 92 | 3 | DB00334 | |
| Drug | Ziprasidone | 1.38e-04 | 25 | 92 | 3 | DB00246 | |
| Drug | Aripiprazole | 1.38e-04 | 25 | 92 | 3 | DB01238 | |
| Drug | (R)-Propranolol hydrochloride [13071-11-9]; Down 200; 13.6uM; PC3; HT_HG-U133A | 1.41e-04 | 195 | 92 | 6 | 5814_DN | |
| Drug | estradiol, USP; Up 200; 0.1uM; HL60; HT_HG-U133A | 1.41e-04 | 195 | 92 | 6 | 2668_UP | |
| Drug | Isometheptene mucate; Up 200; 8.2uM; PC3; HT_HG-U133A | 1.50e-04 | 197 | 92 | 6 | 5082_UP | |
| Drug | Caffeic acid [3331-39-5]; Down 200; 22.2uM; HL60; HT_HG-U133A | 1.54e-04 | 198 | 92 | 6 | 3053_DN | |
| Drug | Oxantel pamoate [68813-55-8]; Down 200; 6.6uM; PC3; HT_HG-U133A | 1.54e-04 | 198 | 92 | 6 | 6738_DN | |
| Drug | Hydrocortisone base [50-23-7]; Up 200; 11uM; MCF7; HT_HG-U133A | 1.54e-04 | 198 | 92 | 6 | 5284_UP | |
| Drug | Clozapine | 1.55e-04 | 26 | 92 | 3 | DB00363 | |
| Drug | Quetiapine | 1.55e-04 | 26 | 92 | 3 | DB01224 | |
| Drug | Ergocryptine-alpha [511-09-1]; Down 200; 7uM; HL60; HT_HG-U133A | 1.58e-04 | 199 | 92 | 6 | 2572_DN | |
| Drug | Atropine | 1.60e-04 | 5 | 92 | 2 | DB00572 | |
| Drug | Darifenacin | 1.60e-04 | 5 | 92 | 2 | DB00496 | |
| Drug | Metixene | 1.60e-04 | 5 | 92 | 2 | DB00340 | |
| Drug | Trihexyphenidyl | 1.60e-04 | 5 | 92 | 2 | DB00376 | |
| Drug | Solifenacin | 1.60e-04 | 5 | 92 | 2 | DB01591 | |
| Drug | 5-(3-(3-hydroxyphenoxy)azetidin-1-yl)-5-methyl-2,2-diphenylhexanamide | 1.60e-04 | 5 | 92 | 2 | ctd:C568516 | |
| Drug | xanomeline | 1.60e-04 | 5 | 92 | 2 | ctd:C075257 | |
| Drug | Pipecuronium | 1.60e-04 | 5 | 92 | 2 | ctd:D017300 | |
| Drug | N-Methylscopolamine | 1.60e-04 | 5 | 92 | 2 | ctd:D019832 | |
| Drug | 1,3-oxathiolane | 1.60e-04 | 5 | 92 | 2 | CID000065092 | |
| Drug | Cryptenamine | 1.60e-04 | 5 | 92 | 2 | DB00785 | |
| Drug | Homatropine Methylbromide | 1.60e-04 | 5 | 92 | 2 | DB00725 | |
| Drug | Fesoterodine | 1.60e-04 | 5 | 92 | 2 | DB06702 | |
| Drug | Scopolamine Derivatives | 1.60e-04 | 5 | 92 | 2 | ctd:D012602 | |
| Drug | Tolterodine | 1.60e-04 | 5 | 92 | 2 | DB01036 | |
| Drug | Quinuclidinyl Benzilate | 1.60e-04 | 5 | 92 | 2 | ctd:D011813 | |
| Drug | nordihydroguaiaretic acid; Up 200; 1uM; PC3; HT_HG-U133A | 1.62e-04 | 200 | 92 | 6 | 4447_UP | |
| Drug | triflupromazine | 1.74e-04 | 27 | 92 | 3 | CID000005568 | |
| Drug | alpha-methylhistamine | 1.94e-04 | 28 | 92 | 3 | CID000003615 | |
| Drug | prochlorperazine | 2.16e-04 | 29 | 92 | 3 | CID000004917 | |
| Drug | Cyproheptadine | 2.40e-04 | 6 | 92 | 2 | DB00434 | |
| Drug | Gallamine Triethiodide | 2.40e-04 | 6 | 92 | 2 | ctd:D005703 | |
| Drug | acetamidofluorescein | 2.40e-04 | 6 | 92 | 2 | CID000134089 | |
| Drug | HUK 978 | 2.40e-04 | 6 | 92 | 2 | CID000065826 | |
| Drug | Scopolamine | 2.40e-04 | 6 | 92 | 2 | DB00747 | |
| Drug | Crotalid Venoms | 2.40e-04 | 6 | 92 | 2 | ctd:D003435 | |
| Drug | brucine N-oxide | 2.40e-04 | 6 | 92 | 2 | ctd:C083067 | |
| Disease | 3-(3-amino-3-carboxypropyl)uridine measurement | 9.20e-06 | 2 | 90 | 2 | EFO_0800632 | |
| Disease | Neurodevelopmental Disorders | 9.92e-06 | 93 | 90 | 5 | C1535926 | |
| Disease | PROSTATE CANCER, HEREDITARY, 1 | 3.46e-05 | 60 | 90 | 4 | C4722327 | |
| Disease | Prostate cancer, familial | 6.01e-05 | 69 | 90 | 4 | C2931456 | |
| Disease | histidine-rich glycoprotein measurement | 1.37e-04 | 6 | 90 | 2 | EFO_0008155 | |
| Disease | attention deficit hyperactivity disorder, substance abuse, antisocial behaviour measurement | UBE2E1 CCDC73 TTC28 JADE2 UBAP2L USP28 AFF3 IGSF11 HERC1 SIPA1L2 | 1.66e-04 | 801 | 90 | 10 | EFO_0003888, EFO_0007052, MONDO_0002491 |
| Disease | protein DEPP measurement | 1.91e-04 | 7 | 90 | 2 | EFO_0801939 | |
| Disease | anosmin-1 measurement | 1.91e-04 | 7 | 90 | 2 | EFO_0802284 | |
| Disease | CD27 antigen measurement | 2.55e-04 | 8 | 90 | 2 | EFO_0008078 | |
| Disease | osteoarthritis, spine, body mass index | 2.55e-04 | 8 | 90 | 2 | EFO_0004340, EFO_1000787 | |
| Disease | gastroesophageal reflux disease | 2.64e-04 | 101 | 90 | 4 | EFO_0003948 | |
| Disease | insulin sensitivity measurement, glucose homeostasis measurement | 3.10e-04 | 43 | 90 | 3 | EFO_0004471, EFO_0006896 | |
| Disease | dual specificity mitogen-activated protein kinase kinase 4 measurement | 3.27e-04 | 9 | 90 | 2 | EFO_0008113 | |
| Disease | chronotype measurement | 3.58e-04 | 882 | 90 | 10 | EFO_0008328 | |
| Disease | fetuin-B measurement | 4.07e-04 | 10 | 90 | 2 | EFO_0008128 | |
| Disease | Pain, Migratory | 4.57e-04 | 49 | 90 | 3 | C0751407 | |
| Disease | Suffering, Physical | 4.57e-04 | 49 | 90 | 3 | C0751408 | |
| Disease | Pain, Crushing | 4.57e-04 | 49 | 90 | 3 | C0458259 | |
| Disease | Pain, Splitting | 4.57e-04 | 49 | 90 | 3 | C0458257 | |
| Disease | Pain | 4.57e-04 | 49 | 90 | 3 | C0030193 | |
| Disease | Radiating pain | 4.57e-04 | 49 | 90 | 3 | C0234254 | |
| Disease | Pain, Burning | 4.57e-04 | 49 | 90 | 3 | C0234230 | |
| Disease | Ache | 4.57e-04 | 49 | 90 | 3 | C0234238 | |
| Disease | age at menarche | 4.69e-04 | 594 | 90 | 8 | EFO_0004703 | |
| Disease | intracranial aneurysm (is_implicated_in) | 5.95e-04 | 12 | 90 | 2 | DOID:10941 (is_implicated_in) | |
| Disease | non-histone chromosomal protein HMG-14 measurement | 5.95e-04 | 12 | 90 | 2 | EFO_0021872 | |
| Disease | thalamus volume change measurement | 8.17e-04 | 14 | 90 | 2 | EFO_0021496 | |
| Disease | lung small cell carcinoma (is_marker_for) | 1.07e-03 | 16 | 90 | 2 | DOID:5409 (is_marker_for) | |
| Disease | Benign neoplasm of stomach | 1.21e-03 | 17 | 90 | 2 | C0153943 | |
| Disease | Neoplasm of uncertain or unknown behavior of stomach | 1.21e-03 | 17 | 90 | 2 | C0496905 | |
| Disease | major depressive disorder (is_marker_for) | 1.21e-03 | 17 | 90 | 2 | DOID:1470 (is_marker_for) | |
| Disease | Carcinoma in situ of stomach | 1.21e-03 | 17 | 90 | 2 | C0154060 | |
| Disease | intellectual disability (implicated_via_orthology) | 1.58e-03 | 75 | 90 | 3 | DOID:1059 (implicated_via_orthology) | |
| Disease | age of onset of asthma | 1.84e-03 | 79 | 90 | 3 | OBA_2001001 | |
| Disease | Joubert syndrome 1 | 1.86e-03 | 21 | 90 | 2 | C4551568 | |
| Disease | Stomach Carcinoma | 1.86e-03 | 21 | 90 | 2 | C0699791 | |
| Disease | Autism Spectrum Disorders | 2.26e-03 | 85 | 90 | 3 | C1510586 | |
| Disease | partial thromboplastin time | 2.43e-03 | 24 | 90 | 2 | EFO_0004310 | |
| Disease | severe acute respiratory syndrome, COVID-19 | 2.49e-03 | 447 | 90 | 6 | EFO_0000694, MONDO_0100096 | |
| Disease | Bradycardia | 2.85e-03 | 26 | 90 | 2 | C0428977 | |
| Disease | white matter integrity, age at assessment | 2.85e-03 | 26 | 90 | 2 | EFO_0004641, EFO_0008007 | |
| Disease | Varicose veins | 2.93e-03 | 193 | 90 | 4 | HP_0002619 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| DTSNESSSGSATQNT | 291 | P08173 | |
| INQSSSLDSSTSSQE | 1306 | P55196 | |
| SSSSSSSDSDLESEQ | 671 | P51826 | |
| SSTAEINETTTSSTD | 2386 | P13611 | |
| STSDSNDESDSQSKS | 1261 | Q9NZW4 | |
| ESSNDSTSVSAVASN | 281 | P08172 | |
| SQTRSESSSQADTSK | 746 | Q8TC27 | |
| HSSDSTSSSSSEDEQ | 356 | Q6PL18 | |
| NSEASSSEGQSSLSS | 1186 | Q5TGY3 | |
| DESPQISSTSSSSSE | 341 | P78312 | |
| SEHSSSTSTSTNQKE | 771 | P78312 | |
| ESSSTNHSIGSTQST | 636 | P17813 | |
| SSDGQSDSQSSENSS | 101 | Q76L83 | |
| SDSQSSENSSSSSDG | 106 | Q76L83 | |
| EVDSNTSSQSSNSES | 561 | Q02297 | |
| TSSQSSNSESETEDE | 566 | Q02297 | |
| RSSSNESFSSNQSTE | 71 | O60268 | |
| IQSSETCSSQDSSTT | 611 | Q96NI6 | |
| KNSTDEVQTSSSFSS | 26 | Q96LL4 | |
| TNSSDSSSQQLVASS | 1156 | O75140 | |
| ESSTSEKTSSTTETN | 5491 | Q8WXI7 | |
| SSQDSEVSTVVSNSS | 1191 | Q8WXG6 | |
| SQDEENASSSQASTS | 86 | O15481 | |
| TTTSSSESDEASSNQ | 76 | A2A368 | |
| ATNSNETSTSANTGS | 21 | Q5SSG8 | |
| QLDEDNSSVSSSSSS | 11 | Q96S65 | |
| TSNSNDTINCSSESS | 476 | Q6DN90 | |
| ASSAQDSTSENSSSV | 1911 | Q2KJY2 | |
| DSSKNSDSQSVSSNT | 366 | Q4FZB7 | |
| SDSQSVSSNTDADTT | 371 | Q4FZB7 | |
| SQSTTSSKSENEIAS | 2451 | Q15751 | |
| SSQSSSSVSSQVTTA | 211 | Q9NXV6 | |
| SSDNSDTTDSHATST | 11 | Q9NQC1 | |
| SCTNTTSSSSEEDKQ | 561 | P56645 | |
| VKQDNESSSSSTSST | 226 | Q8IXQ8 | |
| NISTDDLNTTSSVSS | 896 | Q8IVL0 | |
| STDQQTVSSSSTALA | 621 | Q6ZU69 | |
| STDQQTVSSSSTALA | 351 | Q63HN1 | |
| NFDETSSATTISTSE | 96 | Q8IZD2 | |
| ITDNSSSSDIVESST | 571 | Q9ULI3 | |
| NESDSSSCRTSNSSQ | 166 | Q96PQ7 | |
| SESTSSRHNSESESV | 1026 | Q6R327 | |
| SSHQTGSTSTQTQES | 306 | Q9UBG3 | |
| SASHSSTSQSESDSE | 341 | Q96CX6 | |
| NSSLSSTSETPNEST | 331 | O43182 | |
| ASSNSSNATTSSSEE | 346 | P43694 | |
| TSSSSSDIEDDDQNS | 1201 | P46100 | |
| SLTSTSSESDTGQEA | 1641 | Q9ULT8 | |
| TEISSSDNNTLTSSN | 301 | Q5DX21 | |
| ISSSDENESSQNTSS | 741 | P40189 | |
| QSSTAAAQSASATDT | 331 | Q8NCB2 | |
| TSSVVSTSSNSSDNA | 1676 | Q9H7D0 | |
| ADSAVSLSSSSDQNT | 2806 | Q9H799 | |
| DTSEINSNSDSLNSS | 211 | P19525 | |
| SESNSSSESSESQSE | 51 | O14647 | |
| SSLQSATSDSEQSFD | 761 | Q9HBT6 | |
| NTESSSTFTLQSSSE | 6 | Q6ZRK6 | |
| SSSDSQEALTVSASS | 531 | Q2V2M9 | |
| TSEPESSSEQTTADS | 26 | A6NGH7 | |
| SSSEDSTTPSAQTQE | 526 | P01042 | |
| SSSTESSQSSQDSQP | 721 | Q7Z589 | |
| QSFSRTDSDTTTETA | 356 | P35367 | |
| SSSSSSSNSSNERED | 61 | Q13620 | |
| SSNSSNEREDFDSTS | 66 | Q13620 | |
| NEREDFDSTSSSSST | 71 | Q13620 | |
| SQVSSTSNDVSSSDF | 86 | Q92833 | |
| SEGSENSFQSSSSSV | 26 | Q14995 | |
| SSASSTATSNTEEND | 536 | O94972 | |
| SDSVSAASSSDQQNS | 1041 | Q7Z5M5 | |
| EDSTQTSDTATNSTL | 326 | P21462 | |
| STSTTVSSSGAQNSD | 66 | Q7Z3K3 | |
| SLSSSSNSVSSEEEE | 401 | Q1XH10 | |
| SNTLSSNTSSNSDDK | 1226 | Q9P2F8 | |
| SEESSQDSSENSSES | 131 | Q8N5I9 | |
| EEHSVSENQESSSSS | 156 | Q92954 | |
| SENQESSSSSSSSSS | 161 | Q92954 | |
| DSNASASSSSNEGDS | 496 | Q08945 | |
| TETSESSSESESNNK | 271 | Q86X95 | |
| SSTETSQSQSSHEEF | 731 | Q8WXI2 | |
| SSSTSELATASSGEN | 1056 | P61129 | |
| QSAASDTSSQSEQDT | 1036 | Q8N2C7 | |
| DTSSQSEQDTSECTT | 1041 | Q8N2C7 | |
| DSSLSDNSTRSAQSS | 1496 | Q9BX84 | |
| TSTASESSSTISSNQ | 551 | Q14157 | |
| LSQSTANESSTTLDS | 836 | Q8NB66 | |
| SSTSEEPDENSSSVT | 121 | Q8WVD5 | |
| SESNQDSSTSELSWT | 506 | Q5T4T6 | |
| DSSSTTTETSNPDTE | 1421 | Q92545 | |
| SSSASESNTSTSIVN | 226 | Q9UKY1 | |
| TTATDSSSNSSQKRE | 146 | Q7Z698 | |
| SDQTSKESTSTESSS | 481 | Q96RU2 | |
| DSETVENISSSSTSE | 126 | Q9UBS9 | |
| ESTSSDASQPTSQDS | 41 | P58753 | |
| SDQSSTETDSTVKSQ | 2136 | Q96AY4 | |
| SQSSDSFSQDTSVTL | 611 | Q6ZSB9 | |
| SSSSSSSSNQQTEKE | 11 | P51965 | |
| STSNSQSDLFSEETT | 51 | Q9H8U3 | |
| SEETTSDNNNTSITT | 61 | Q9H8U3 | |
| STTSTNDASQKESSA | 141 | Q6ZSZ6 | |
| SVQSTQSNGSESSSS | 2536 | O75962 | |
| SQSNDSSDSDSSSSQ | 1666 | O95071 | |
| TNSLNSDVSSESSDS | 101 | Q99612 | |
| ETSPSSNNSSEELSS | 6 | Q8N987 |